NOK 8.4
(-5.83%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 6.45 Million NOK | 48.14% |
2022 | 4.35 Million NOK | 61.44% |
2021 | 2.69 Million NOK | 0.0% |
2020 | - NOK | 0.0% |
2019 | - NOK | 0.0% |
2018 | - NOK | -100.0% |
2017 | 2.26 Million NOK | 825.88% |
2016 | 245 Thousand NOK | 0.0% |
2015 | - NOK | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 12.18 Million NOK | 166.61% |
2024 Q1 | 4.57 Million NOK | -29.14% |
2023 Q2 | 7.55 Million NOK | 239.86% |
2023 Q4 | 6.45 Million NOK | 167.86% |
2023 FY | 6.45 Million NOK | 48.14% |
2023 Q1 | 2.22 Million NOK | -48.93% |
2023 Q3 | 2.4 Million NOK | -68.13% |
2022 Q3 | - NOK | -100.0% |
2022 FY | 4.35 Million NOK | 61.44% |
2022 Q2 | 6.41 Million NOK | 0.0% |
2022 Q4 | 4.35 Million NOK | 0.0% |
2021 Q4 | 2.69 Million NOK | 0.0% |
2021 FY | 2.69 Million NOK | 0.0% |
2021 Q2 | 3.35 Million NOK | 0.0% |
2020 Q4 | - NOK | 0.0% |
2020 FY | - NOK | 0.0% |
2019 Q4 | - NOK | 0.0% |
2019 Q2 | -6646.00 NOK | 0.0% |
2019 FY | - NOK | 0.0% |
2018 Q4 | - NOK | 0.0% |
2018 Q2 | 2.44 Million NOK | 0.0% |
2018 FY | - NOK | -100.0% |
2017 FY | 2.26 Million NOK | 825.88% |
2017 Q4 | 2.26 Million NOK | 0.0% |
2016 FY | 245 Thousand NOK | 0.0% |
2015 FY | - NOK | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Gentian Diagnostics ASA | 9 Million NOK | 28.379% |
Medistim ASA | 9.26 Million NOK | 30.343% |